Search results
PROMOTED
Start date:
Jun 10, 2026
Transcatheter edge-to-edge repair (TEER) is rapidly emerging as an important treatment option for patients with tricuspid regurgitation. Successful procedures require a detailed understanding of tricuspid valve anatomy, precise imaging guidance, and thoughtful procedural planning—especially in complex anatomies.This webinar brings together leading experts Prof Andrew Cook (UCL Institute…
View more
Transcatheter Therapies for FMR
Added:
1 year ago
Review Article
Added:
10 months ago
EuroPCR 25 - Real-world registry findings show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR).We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from two large-scale Japanese registries,…
View more
Added:
3 months ago
Discover the complexities of assessing right ventricular function in tricuspid regurgitation with Dr Alison DuncanThis presentation, part of a comprehensive series on complex cases in interventional cardiology, explores the challenges and evolving approaches to RV function assessment when traditional imaging parameters fall short.Dr Duncan addresses the fundamental limitations of conventional…
View more
Mitral and Tricuspid Transcatheter Edge-to-Edge Repair
Added:
1 year ago
Review Article
Added:
2 weeks ago
ACC.26 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined onsite by principal investigator Dr Wayne Batchelor (Inova Schar Heart and Vascular, US) to discuss the ALERT trial. ALERT is a pragmatic, multicentre, cluster-randomised study evaluating the Tempus Next platform, which continuously scans echocardiography reports to identify patients with severe aortic stenosis…
View more
Added:
1 year ago
Learn from your interventional, imaging and heart failure colleagues about the latest in recognizing and treating patients with mitral and tricuspid valve disease. Explore case-based discussions, brush up on the latest clinical data and guidelines and learn more about new approved technologies for your valvular disease patients.
View more
Added:
5 months ago
TCT 2025 - Sub-anlysis findings showed positive safety and efficacy outcomes of the PASCAL Precision system in degenerative mitral regurgitation (DMR) patients.Dr P Kasi Ramanathan (Promedica Toledo Hospital, OH, US) joins us on-site at TCT 2025 to share the findings from a sub-analysis looking at the affect of implant location and leaflet lesion location on the safety and effectiveness of the…
View more
Added:
1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP…
View more
Added:
1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,…
View more